These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 18667766

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
    Hsiao PJ, Kuo KK, Shin SJ, Yang YH, Lin WY, Yang JF, Chiu CC, Chuang WL, Tsai TR, Yu ML.
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
    Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C, Trovato FM, Catalano D.
    Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
    Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Oza N, Nakashita S, Hara M, Iwane S, Takahashi H, Akiyama T, Ario K, Kawaguchi Y, Yasutake T, Iwakiri R, Ozaki I, Hisatomi A, Eguchi T, Ono N, Fujimoto K.
    Liver Int; 2009 Feb; 29(2):213-20. PubMed ID: 18710430
    [Abstract] [Full Text] [Related]

  • 27. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
    Mao JF, Wu XY, Li NS, Lu SY, Jing ZM, Shi YF.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2550-2. PubMed ID: 19080648
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY, Pan JQ, Lv JH.
    Zhongguo Zhong Yao Za Zhi; 2008 Oct 23; 33(20):2385-90. PubMed ID: 19157135
    [Abstract] [Full Text] [Related]

  • 30. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, Fujino T, Aoyagi Y, Fukuizumi K, Yoshimoto T, Takemoto R, Miyahara T, Harada N, Hayata F, Nakashima M, Enjoji M.
    Scand J Gastroenterol; 2009 Oct 23; 44(4):471-7. PubMed ID: 19058085
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA, Barakat YA.
    Saudi Med J; 2008 Feb 23; 29(2):185-92. PubMed ID: 18246224
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB, Haffner SM.
    Diabetes Care; 2007 Jul 23; 30(7):1819-27. PubMed ID: 17429060
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.
    Abdelmalek MF, Liu C, Shuster J, Nelson DR, Asal NR.
    Clin Gastroenterol Hepatol; 2006 Sep 23; 4(9):1162-9. PubMed ID: 16901766
    [Abstract] [Full Text] [Related]

  • 37. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
    Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, Arcaro G.
    Nutr Metab Cardiovasc Dis; 2007 Sep 23; 17(7):517-24. PubMed ID: 16928437
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P.
    Am J Physiol Endocrinol Metab; 2006 Aug 23; 291(2):E282-90. PubMed ID: 16478772
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.